Research and Markets: Emerging Markets Clinical Development Series: Brazil, Russia, India and China (BRIC)

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/918ee8/emerging_markets_c) has announced the addition of Cutting Edge Information's new report "Emerging Markets Clinical Development Series: Brazil, Russia, India and China (BRIC)" to their offering.

The next frontier of global industry expansion makes its home in Brazil, Russia, India and China (BRIC). Imagine the impact of a patient pool that numbers 3 billion, an immediate cure for patient shortages (or recruitment challenges) that plague studies in North America and Western Europe, unparalleled access to untapped patient populations, and new opportunities to meet the growing medical needs of these countries.

Despite vast promise as the next major growth opportunity for life sciences companies, the BRIC countries collectively represent a daunting challenge to new product development strategists and clinical operations teams. Any number of unknowns, unfamiliar regulatory guidelines, intellectual property concerns, time and distance barriers, and tolerance of dishonest business practices, can cause companies to hesitate to invest in these emerging markets or keep them out altogether.

Confidently tap into the potential of the BRIC markets, fulfill protocol, and ultimately, realize significant cost and time savings. Expand your understanding of BRIC, individually and as a whole, using rankings data and best practices to map out a winning clinical strategy:

  • Eliminate confusion: Weigh the advantages and drawbacks of different countries and examine rankings for 13 clinical factors to enable strategic decision- making. Gain quick access to relevant demographics and economics information for a comprehensive analysis of the clinical environment.
  • Master trial management: Learn from top executives firsthand experiences, both successes and misfires. Recommendations show your team how to improve CRO selection, management and oversight, and more. Explore 23 in-depth profiles and find one that matches your companys situation.
  • Clarify misperceptions: Differences in cultural attitudes and behavior impact trial success. Knowledge and awareness go a long way in cultivating strong and beneficial relationships with local CROs.

Key Topics Covered:

Executive Summary:

  • Scoring BRIC
  • Study Methodology
  • Participating Companies
  • Report Layout
  • Profile Layout

Running Trials in BRIC Countries: Key Recommendations for Success

Brazil:

  • Clinical Environment Overview
  • Clinical Development Strategy
  • Clinical Development Profiles

Russia:

  • Clinical Environment Overview
  • Clinical Development Strategy
  • Best Practices
  • Clinical Development Profiles

India:

  • Clinical Environment Overview
  • Clinical Development Strategy
  • Clinical Development Profiles

China:

  • Clinical Environment Overview
  • Clinical Development Strategy
  • Clinical Development Profiles

For more information visit http://www.researchandmarkets.com/research/918ee8/emerging_markets_c

Contacts

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716